ABT-263(Navitoclax)

Product information

323,40 $

Beschreibung

Beschreibung

ABT-263 (Navitoclax) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki ~ 0.5 nM, 1 nM and 1 nM in cell-free assays. ABT-263 blocks the Bcl-2/Bcl-xL interactions, thereby promoting apoptosis.

Übersicht

Übersicht

Powder; no buffer, Souce: chemical synthesis, Buffer: Powder; no buffer

Additional details

Downloads

Downloads

http://www.ubpbio.com/temp/F7140%20F7141_ABT-263%20(Navitoclax)_Datasheet.pdf

Artikelnummer

UBP-F7141

Herstellerartikelnummer

F7141

Einheit

25 mg